JMP Securities Initiates Coverage On Privia Health Gr with Market Outperform Rating, Announces Price Target of $27
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Constantine Davides has initiated coverage on Privia Health Group (NASDAQ:PRVA) with a Market Outperform rating and set a price target of $27.

December 06, 2023 | 10:56 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Privia Health Group has been given a Market Outperform rating and a price target of $27 by JMP Securities analyst Constantine Davides.
Analyst ratings, especially initiations of coverage with positive outlooks, can lead to increased investor confidence and potential stock price appreciation. The Market Outperform rating suggests that the analyst believes PRVA will perform better than the broader market, and the specific price target of $27 provides a clear expectation for future price movement. Given that this is new coverage, it may attract investor attention and drive short-term price action towards the target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100